Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

adult ADHD

This page shows the latest adult ADHD news and features for those working in and with pharma, biotech and healthcare.

Shire claims FDA approval for slow-cooked ADHD drug

Shire claims FDA approval for slow-cooked ADHD drug

After more than a decade, Shire has finally won approval in the US for its long-acting attention deficit hyperactivity disorder drug (ADHD) Mydayis. ... Being able to take a single dose is important, according to Shire because it is thought that more

Latest news

  • Shire pitching at adult ADHD product launch in 2017 Shire pitching at adult ADHD product launch in 2017

    Shire wants to develop a drug called SHP465 (triple-bead mixed amphetamine salts) for adult ADHD, but to satisfy the FDA will have to first carry out a trial of the ... Breaking into the adult ADHD - as well as a sideways move into binge-eating disorder

  • Lilly’s Strattera wins new adult ADHD licence in UK Lilly’s Strattera wins new adult ADHD licence in UK

    It is the first time a drug has gained ADHD approval in the EU for a specific adult use, and marks an important step for adults diagnosed with ADHD who were ... King's College London and president of the UK Adult ADHD Network (UKAAN), “and because

  • Therapy focus: ADHD

    In fact, ADHD affects about 2 per cent of the world's adult population and as many as 65 per cent of children with ADHD may still have symptoms as adults. ... Around two-thirds of young offenders and up to half of the adult prison population have ADHD.

  • Targacept ADHD drug fails phase II study

    An investigational treatment for adults with attention deficit/hyperactivity disorder (ADHD) that is being developed through partnership between AstraZeneca and Targacept has failed to meet the primary endpoint of a phase ... Top-line results of the

  • Shire boosted by Vyvanse

    in contrast to other branded ADHD treatments that have lost market share," said Angus Russell, Shire, CEO. ... We are anticipating the benefits of the back to school season for Vyvanse and are looking forward to increased sales momentum from our

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Challenging perceptions Challenging perceptions

    We are providing support to have a greater understanding of adult ADHD newly-diagnosed patients anwd get information on many domains of their life to better understand how the condition is ... At European level there is the adult ADHD indication - we are

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Neurodiversity, ADHD and work: Obstacles and opportunities

    Hodgkins, P. (2012). Distinguishing comorbidity and successful management of adult ADHD. Journal of attention disorders,  16(5_suppl), 3S-19S. ... 12. Hupfeld, K. E., Abagis, T. R., &Shah, P. (2018). Living “in the zone”: hyperfocus in adult

  • ADHD perspectives series

    The ADHD in practice editorial board looks to represent this multi-disciplinary team providing insight and opinion. ... ADHD community can work together to provide the personalised 'scaffolding' from their perspective.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Quick links

Infographics

Multimedia